Eric E. Easom

978 total citations
16 papers, 499 citations indexed

About

Eric E. Easom is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Eric E. Easom has authored 16 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 7 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in Eric E. Easom's work include HIV/AIDS drug development and treatment (6 papers), Malaria Research and Control (4 papers) and Herpesvirus Infections and Treatments (3 papers). Eric E. Easom is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), Malaria Research and Control (4 papers) and Herpesvirus Infections and Treatments (3 papers). Eric E. Easom collaborates with scholars based in United States, China and Switzerland. Eric E. Easom's co-authors include Jacob J. Plattner, Yvonne R. Freund, Yong-Kang Zhang, Philip J. Rosenthal, Robert T. Jacobs, Min Ge, Francisco‐Javier Gamo, David Waterson, Lingchao Li and Yasheen Zhou and has published in prestigious journals such as Nature Communications, Journal of Medicinal Chemistry and Tetrahedron Letters.

In The Last Decade

Eric E. Easom

16 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric E. Easom United States	14	194	174	124	105	93	16	499
Franklin Souza‐Silva Brazil	18	147 0.8×	193 1.1×	390 3.1×	213 2.0×	130 1.4×	50	742
Preeti Vishwakarma India	17	419 2.2×	191 1.1×	393 3.2×	270 2.6×	133 1.4×	42	852
Ganesh Chandra Sahoo India	14	66 0.3×	186 1.1×	273 2.2×	168 1.6×	54 0.6×	35	474
Susan E. Leed United States	15	249 1.3×	149 0.9×	313 2.5×	217 2.1×	52 0.6×	26	584
María José Lafuente-Monasterio Spain	13	69 0.4×	150 0.9×	274 2.2×	90 0.9×	105 1.1×	14	459
Pamela Berry United States	11	74 0.4×	105 0.6×	37 0.3×	46 0.4×	63 0.7×	14	274
Emanuela Nizi Italy	13	302 1.6×	238 1.4×	79 0.6×	96 0.9×	159 1.7×	19	609
Carla D. Lopes Brazil	16	228 1.2×	167 1.0×	100 0.8×	220 2.1×	19 0.2×	38	622
Saroj Kumar Panda India	12	61 0.3×	217 1.2×	26 0.2×	49 0.5×	150 1.6×	27	400
Stefanie K. Menzies United Kingdom	12	50 0.3×	127 0.7×	47 0.4×	72 0.7×	73 0.8×	22	381

Countries citing papers authored by Eric E. Easom

Since Specialization

Citations

This map shows the geographic impact of Eric E. Easom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric E. Easom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric E. Easom more than expected).

Fields of papers citing papers by Eric E. Easom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric E. Easom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric E. Easom. The network helps show where Eric E. Easom may publish in the future.

Co-authorship network of co-authors of Eric E. Easom

This figure shows the co-authorship network connecting the top 25 collaborators of Eric E. Easom. A scholar is included among the top collaborators of Eric E. Easom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric E. Easom. Eric E. Easom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Padilla, Ángel M., Wei Wang, Tsutomu Akama, et al.. (2022). Discovery of an orally active benzoxaborole prodrug effective in the treatment of Chagas disease in non-human primates. Nature Microbiology. 7(10). 1536–1546. 39 indexed citations

Eckburg, Paul B., Dave Clarke, Jennifer Long, et al.. (2022). 1727. Phase 1b Dose-ranging Study Demonstrates Tolerability and Pharmacokinetics (PK) of Oral Epetraborole at the Predicted Therapeutic Dosage for Mycobacterium avium Complex (MAC) Lung Disease. Open Forum Infectious Diseases. 9(Supplement_2). 4 indexed citations

Ehrens, Alexandra, Christopher S. Lunde, Robert T. Jacobs, et al.. (2020). In vivo efficacy of the boron-pleuromutilin AN11251 against Wolbachia of the rodent filarial nematode Litomosoides sigmodontis. PLoS neglected tropical diseases. 14(1). e0007957–e0007957. 12 indexed citations

Wu, Wesley, Jenny Legac, Eric E. Easom, et al.. (2020). Plasmodium falciparum Resistance to a Lead Benzoxaborole Due to Blocked Compound Activation and Altered Ubiquitination or Sumoylation. mBio. 11(1). 21 indexed citations

Lunde, Christopher S., Erin E. Stebbins, Rajiv S. Jumani, et al.. (2019). Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis. Nature Communications. 10(1). 2816–2816. 44 indexed citations

Carter, David S., Robert T. Jacobs, Yvonne R. Freund, et al.. (2019). Macrofilaricidal Benzimidazole–Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 2. Ketone Linked Analogs. ACS Infectious Diseases. 6(2). 180–185. 16 indexed citations

Palencia, Andrés, Alexandre Bougdour, Marie‐Pierre Brenier‐Pinchart, et al.. (2017). Targeting Toxoplasma gondii CPSF 3 as a new approach to control toxoplasmosis. EMBO Molecular Medicine. 9(3). 385–394. 59 indexed citations

Zhang, Yong-Kang, Jacob J. Plattner, Eric E. Easom, et al.. (2017). Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate. Journal of Medicinal Chemistry. 60(13). 5889–5908. 53 indexed citations

Akama, Tsutomu, Yong-Kang Zhang, Yvonne R. Freund, et al.. (2017). Identification of a 4-fluorobenzyl l-valinate amide benzoxaborole (AN11736) as a potential development candidate for the treatment of Animal African Trypanosomiasis (AAT). Bioorganic & Medicinal Chemistry Letters. 28(1). 6–10. 33 indexed citations

10.

Zhang, Yong-Kang, Jacob J. Plattner, Eric E. Easom, et al.. (2016). Optimization of isoxazoline amide benzoxaboroles for identification of a development candidate as an oral long acting animal ectoparasiticide. Bioorganic & Medicinal Chemistry Letters. 26(13). 3182–3186. 19 indexed citations

11.

Zhang, Yong-Kang, Jacob J. Plattner, Eric E. Easom, et al.. (2015). Discovery of an orally bioavailable isoxazoline benzoxaborole (AN8030) as a long acting animal ectoparasiticide. Bioorganic & Medicinal Chemistry Letters. 25(23). 5589–5593. 26 indexed citations

12.

Zhang, Yong-Kang, Jacob J. Plattner, Eric E. Easom, et al.. (2015). Benzoxaborole Antimalarial Agents. Part 4. Discovery of Potent 6-(2-(Alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles. Journal of Medicinal Chemistry. 58(13). 5344–5354. 29 indexed citations

13.

Plattner, Jacob J., et al.. (2012). Benzoxaborole antimalarial agents. Part 3: design and syntheses of (carboxy‐¹³C‐3,3‐²H₂)‐labeled and (3‐¹⁴C)‐labeled 7‐(2‐carboxyethyl)‐1,3‐dihydro‐1‐hydroxy‐2,1‐benzoxaboroles. Journal of Labelled Compounds and Radiopharmaceuticals. 55(6). 201–205. 13 indexed citations

14.

Zhang, Yong-Kang, Jacob J. Plattner, Yvonne R. Freund, et al.. (2011). Benzoxaborole antimalarial agents. Part 2: Discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles. Bioorganic & Medicinal Chemistry Letters. 22(3). 1299–1307. 43 indexed citations

15.

Zhang, Yong-Kang, Jacob J. Plattner, Eric E. Easom, et al.. (2011). An efficient synthesis for a new class antimalarial agent, 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole. Tetrahedron Letters. 52(30). 3909–3911. 26 indexed citations

16.

Zhang, Yong-Kang, Jacob J. Plattner, Yvonne R. Freund, et al.. (2010). Synthesis and structure–activity relationships of novel benzoxaboroles as a new class of antimalarial agents. Bioorganic & Medicinal Chemistry Letters. 21(2). 644–651. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact